Is a tuberculin skin test (TST) result below 5mm considered negative?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tuberculin Skin Test Interpretation: Risk-Stratified Thresholds

No, a tuberculin skin test (TST) below 5mm is NOT universally negative—interpretation depends entirely on the patient's risk category, and for high-risk individuals, even <5mm may warrant clinical action.

Risk-Stratified Interpretation Thresholds

The TST must be interpreted using risk-stratified cutoffs, not a single universal threshold 1:

≥5mm is Positive for High-Risk Groups:

  • Close contacts of active TB cases 1
  • HIV-infected persons 1
  • Immunosuppressed patients (organ transplant recipients, chronic corticosteroid users ≥15mg prednisone daily for ≥1 month) 1
  • Patients on TNF-alpha blocking agents 1
  • Persons with chest radiograph findings suggestive of prior TB (fibrotic changes, apical scarring) 1

≥10mm is Positive for Moderate-Risk Groups:

  • Foreign-born persons from high TB prevalence countries 1, 2
  • Healthcare workers with occupational TB exposure risk 1, 2
  • Residents and employees of high-risk congregate settings (correctional facilities, nursing homes, homeless shelters) 1
  • Injection drug users 1
  • Persons with medical conditions increasing TB progression risk (diabetes, chronic renal failure, silicosis, malignancies, gastrectomy) 1
  • Children <5 years exposed to high-risk adults 1

≥15mm is Positive for Low-Risk Groups:

  • Persons with no known TB risk factors 1, 2
  • Healthcare workers in minimal-risk facilities with essentially no TB exposure 1

Critical Clinical Caveat: False-Negative TST Results

A negative TST (<5mm) does NOT exclude TB disease or infection in high-risk populations 3. False-negative rates are substantial:

  • 10% of immunocompetent children with culture-confirmed TB have negative TST initially 3
  • Up to 50% of patients with miliary TB or TB meningitis have negative TST 3
  • 61% of HIV-infected TB patients may have negative TST, with rates increasing as CD4 counts decline 4, 3
  • 50% of patients on immunosuppressive therapy have negative TST despite active TB 4

When to Proceed Despite Negative TST:

For high-risk patients, clinical suspicion should drive diagnostic workup, not TST results 3. Proceed with full TB evaluation (chest radiograph, sputum AFB smear/culture, nucleic acid amplification testing) if the patient has 3:

  • Persistent cough (>2-3 weeks)
  • Abnormal chest radiograph
  • Known exposure to active TB case
  • HIV infection or other severe immunosuppression
  • Membership in high-risk epidemiologic groups

Special Timing Considerations

Window Period for Recent Exposures:

  • TST performed <8 weeks after TB exposure is unreliable and should be repeated at 8-10 weeks post-exposure 1, 2
  • For children <5 years and immunocompromised contacts with initial TST <5mm and exposure <8 weeks prior, initiate "window prophylaxis" (presumptive LTBI treatment) after excluding active disease, then retest at 8-10 weeks 1

Booster Phenomenon:

  • Delayed-type hypersensitivity can wane over time, and a subsequent TST can "boost" the response, mimicking conversion 1, 2
  • Two-step testing (second test 1-3 weeks after initial negative) is recommended for baseline screening of healthcare workers without documented negative TST in preceding 12 months 2, 1

Common Pitfalls to Avoid

  • Measuring erythema instead of induration leads to incorrect interpretation—only measure the palpable, raised, hardened area transverse to the long axis of the forearm 1, 2
  • Reading outside the 48-72 hour window reduces accuracy 1, 2
  • Ignoring risk stratification and applying a universal 10mm or 15mm cutoff misses high-risk patients who need treatment at ≥5mm 1
  • Dismissing BCG vaccination history as explanation for positive TST—in adults vaccinated as children who are from high TB prevalence countries or are TB contacts, a ≥10mm reaction likely represents true M. tuberculosis infection, not BCG effect 1
  • Relying on patient self-reading—TST must be read by trained healthcare personnel using proper palpation technique 1, 2

Documentation Requirements

Always record TST results in millimeters of induration, never simply as "positive" or "negative" 1, 2. Record 0mm if no induration is present 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

PPD Screening for Tuberculosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Limitations and Clinical Implications of Tuberculin Skin Testing in Diagnosing Active Tuberculosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Tuberculin test responses of tuberculosis patients].

Archivos de bronconeumologia, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.